EPO and infection: Overall, our data demonstrate that NCL-EPO-NPs inhibit C. albicans hyphal growth, which has broader implications on virulence in terms of reduced invasion and biofilm growth, resulting in containment of infection and ridding of drug-resistant biofilms.